CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 87 filers reported holding CARDIFF ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $545,458 | -2.6% | 392,307 | +2.9% | 0.00% | – |
| Q2 2023 | $560,290 | -17.9% | 381,150 | -7.8% | 0.00% | – |
| Q1 2023 | $682,278 | +117941.2% | 413,502 | 0.0% | 0.00% | – |
| Q4 2022 | $578 | -99.9% | 413,502 | -0.2% | 0.00% | – |
| Q3 2022 | $638,000 | -29.6% | 414,372 | +0.5% | 0.00% | – |
| Q2 2022 | $906,000 | -45.5% | 412,110 | -38.5% | 0.00% | – |
| Q1 2022 | $1,661,000 | -57.1% | 669,829 | +3.8% | 0.00% | – |
| Q4 2021 | $3,876,000 | -0.0% | 645,084 | +10.8% | 0.00% | -100.0% |
| Q3 2021 | $3,877,000 | +13.2% | 582,157 | +13.0% | 0.00% | – |
| Q2 2021 | $3,424,000 | +77.4% | 514,981 | +147.0% | 0.00% | – |
| Q1 2021 | $1,930,000 | -47.1% | 208,455 | +2.7% | 0.00% | -100.0% |
| Q4 2020 | $3,649,000 | +141.3% | 202,886 | +90.4% | 0.00% | – |
| Q3 2020 | $1,512,000 | +652.2% | 106,559 | +164.6% | 0.00% | – |
| Q2 2020 | $201,000 | – | 40,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,000 | $63 | 0.04% |
| FinDec Wealth Services, Inc. | 16,000 | $22,240 | 0.02% |
| DENVER WEALTH MANAGEMENT, INC. | 18,235 | $25,347 | 0.02% |
| Atom Investors LP | 18,298 | $25,434 | 0.01% |
| Laurion Capital Management LP | 722,100 | $1,003,719 | 0.01% |
| MAI Capital Management | 224,749 | $312,401 | 0.01% |
| Callan Capital, LLC | 31,147 | $43,294 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 25,975 | $36 | 0.00% |
| Tortoise Investment Management, LLC | 15,000 | $20,850 | 0.00% |
| America First Investment Advisors, LLC | 4,000 | $5,560 | 0.00% |